AMY SMITH: Open Payments
NPI 1306407648 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 31 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $330 · 2025 $995
Food & beverage: $993Speaker / faculty: $2
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $186 |
| Endo USA, Inc. | 5 | $129 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $110 |
| Procept Biorobotics Corporation | 2 | $102 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $87 |
| 180 Medical, Inc. | 1 | $85 |
| Calyxo, Inc. | 2 | $45 |
| Boston Scientific Corporation | 3 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| UROGEN PHARMA, INC. | 1 | $31 |
Products named: GEMTESA, XIAFLEX, AQUABEAM ROBOTIC SYSTEM, PYLARIFY, GENTLECATH, Xtandi, CVAC ASPIRATION SYSTEM, KISQALI.
Industry payments across WA — which companies pay providers there.
